RVL Pharmaceuticals plc (RVLPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Nov 7, 2025, 4:00 PM EST
RVL Pharmaceuticals Market Cap
RVL Pharmaceuticals has a market cap or net worth of $111 as of November 7, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
111.00
Enterprise Value
n/a
Revenue
36.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 18, 2018, RVL Pharmaceuticals's market cap has decreased from 419.90M to 111.00, a decrease of -100.00%. That is a compound annual growth rate of -88.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 111.00 | - |
| Dec 31, 2024 | 111.00 | -99.97% |
| Dec 29, 2023 | 334.22K | -99.70% |
| Dec 30, 2022 | 111.05M | 23.46% |
| Dec 31, 2021 | 89.95M | -65.11% |
| Dec 31, 2020 | 257.85M | -28.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.15M |
| Elite Pharmaceuticals | 659.64M |
| Glass House Brands | 595.49M |
| Northwest Biotherapeutics | 373.25M |
| American Oncology Network | 326.52M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 308.64M |
| Silence Therapeutics | 294.74M |